Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06650527 · ClinicalTrials.gov registry record · NA
Effect of Cognitive Empathy Training on Dementia Caregivers
A NA study of Dementia and Caregivers of People Living With Dementia, sponsored by Emory University.
- Recruiting
- Registry status
- NA
- Development phase
- 118
- Enrollment target
- 3
- Study locations
NCT06650527: Recruiting NA study of Dementia and Caregivers of People Living With Dementia, sponsored by Emory University.
NCT06650527 is a NA study of Dementia and Caregivers of People Living With Dementia that is actively recruiting participants, run by Emory University. The registered enrollment target is 118 participants, below the 7,722-participant average among 199 other Dementia trials with a reported enrollment target (98% lower). The trial reports 3 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06650527, a NA study of Dementia and Caregivers of People Living With Dementia, is actively recruiting participants, sponsored by Emory University.
- RECRUITING
- Registry status
- NA
- Development phase
- 118 participants
- Enrollment target
- 3
- Study locations
Study Summary
The goal of this project is to investigate the effect of cognitive empathy training on mental health, inflammation, and immune function in caregivers of people living with dementia (PLWD), and to examine the underlying psychological and neurobiological mechanisms. The primary aim is to establish the effectiveness of cognitive empathy training in improving caregiver mental health and immune function, and in decreasing caregiver inflammation The secondary aim is to investigate the psychological and neurobiological mechanism by which cognitive empathy training improves caregiver well-being
Primary Outcome
Zarit Burden Inventory (ZBI) score is a 22-item Likert scale. Each item is a statement which the caregiver is asked to endorse using a 5-point scale. Response options range from 0 (Never) to 4 (Nearly Always). Total score is obtained by summing all items endorsed. Higher scores indicate greater perceived burden.
Conditions Studied
Interventions
- BEHAVIORAL Cognitive Empathy Training
- BEHAVIORAL Control Condition
- PROCEDURE Pre and post intervention blood spot collection
- PROCEDURE Pre and post intervention MRI session
Study Locations (3)
Georgia
- Alter - Atlanta
- Emory Integrated Memory Care - Atlanta
- NIA Goizueta Alzheimer's Disease Research Center - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 118 participants |
| Start Date | 2025-02-13 |
| Est. Completion | 2028-11-01 |
| Phase | NA |
What NCT06650527 shows while recruiting
NCT06650527 is an interventional study that assigns participants to a tested intervention. The registered 118 participants enrollment target is mid-sized for trials with a published cap, below the 7,722-participant average among 199 other Dementia trials with a reported enrollment target (98% lower).
The record links to 2 conditions, with Dementia appearing as the primary indexed condition, and to 4 interventions - of which Cognitive Empathy Training is the first listed.
NCT06650527 reports a single indexed study location in Georgia.
Frequently Asked Questions
What is clinical trial NCT06650527 about?
NCT06650527 is a clinical study titled "Effect of Cognitive Empathy Training on Dementia Caregivers". The goal of this project is to investigate the effect of cognitive empathy training on mental health, inflammation, and immune function in caregivers of people living with dementia (PLWD), and to examine the underlying psychological and neurobiological mechanisms. The primary aim is to establish th...
What is the current status of trial NCT06650527?
This trial is currently recruiting. It is a NA study. The enrollment target is 118 participants. The study started on 2025-02-13. Estimated completion is 2028-11-01.
What conditions does trial NCT06650527 study?
This clinical trial studies the following conditions: Dementia, Caregivers of People Living With Dementia.
What interventions are being tested in trial NCT06650527?
The interventions under investigation include: Cognitive Empathy Training (BEHAVIORAL), Control Condition (BEHAVIORAL), Pre and post intervention blood spot collection (PROCEDURE), Pre and post intervention MRI session (PROCEDURE).
Who is sponsoring clinical trial NCT06650527?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06650527 being conducted?
This trial has 3 study locations across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dementia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06650527's enrollment target sits among peer trials
118 113th of 199 higher than 87 of 199 other Dementia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Dementia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
δ in Dementia Clinical Trials
RECRUITING · NA
-
Caregiver as Navigator: Develop Skills Online (CAN-DO)
RECRUITING · NA
-
Connect-Home: Alzheimer's Disease and Related Dementias
RECRUITING · NA
-
Caregiver Bootcamp
RECRUITING · NA
-
Enhancing Triadic Communication About Cognition for Older Adults With Alzheimer's Disease or Related Dementias Facing a Cancer Management Decision
RECRUITING · NA
-
Enhancing Shared Decision-making to Guide Care for People With Dementia and Diabetes
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03821623 · 118 participants · Phase 2
Nicotinamide Riboside for Treating Elevated Systolic Blood Pressure and Arterial Stiffness in Middle-aged and Older Adults
- NCT04040959 · 118 participants · Phase 2
Nicotinamide Riboside Supplementation for Treating Arterial Stiffness and Elevated Systolic Blood Pressure in Patients With Moderate to Severe CKD
- NCT04696029 · 118 participants · Phase 2
DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma
- NCT05223192 · 118 participants · NA
The Effects of Entrainment on Respiratory Stability and Cerebral Oxygenation in Preterm Infants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI